
XenoTherapeutics Inc. and Xeno Acquisition Corp, a non-profit biotechnology company, on Friday agreed to acquire Repare Therapeutics Inc. (NASDAQ:RPTX).
Repare shareholders will receive a cash payment per Common Share, determined based on Repare’s cash balance at closing of the transaction, after deducting certain transaction costs and the aggregate amount of outstanding liabilities.